CHIC-STS01
Institut Claudius Regaud
Institut Claudius Regaud
Advenchen Laboratories, LLC
Institut National de la Santé Et de la Recherche Médicale, France
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Intensity Therapeutics, Inc.
Polaris Group
Eli Lilly and Company
UNICANCER
Gustave Roussy, Cancer Campus, Grand Paris
Universität Münster
UNICANCER
Helsinki University Central Hospital
Rain Oncology Inc
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
ImmunityBio, Inc.
Philogen S.p.A.
Mount Sinai Hospital, Canada
Children's Oncology Group
Karolinska University Hospital
Centre Leon Berard
Children's Oncology Group
Eisai Inc.
Gradalis, Inc.
Children's Oncology Group
University Hospital Tuebingen
Children's Oncology Group
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
University of South Florida
Sheffield Teaching Hospitals NHS Foundation Trust
European Organisation for Research and Treatment of Cancer - EORTC
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Children's Oncology Group
Italian Sarcoma Group
M.D. Anderson Cancer Center
Institut Claudius Regaud
Gustave Roussy, Cancer Campus, Grand Paris
Xian-Janssen Pharmaceutical Ltd.
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Threshold Pharmaceuticals
GOG Foundation
Sanofi
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
University of South Florida
Technical University of Munich
Pfizer
Merck Sharp & Dohme LLC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC